WE believe
portfolio
alpha
TEAM
IMPACT
Impact Report 2025
Impact Report 2024
Impact Report 2023
Impact Report 2022
Impact Report 2021
news & INSIGHTS
Ayala Pharmaceuticals to Present Preclinical Data at AACR for AL101, a Pan-Notch Inhibitor Being Evaluated for Adenoid Cystic Carcinoma